Bristol Myers Squibb (BMY) Shares Outstanding (Weighted Average) (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $2.0 billion in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) changed 0.34% year-over-year to $2.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 billion (changed 0.34% YoY) and the FY2025 annual result came in at $2.0 billion, changed 0.35% from the prior year.
• Shares Outstanding (Weighted Average) held at $2.0 billion in Q1 2026 per BMY's latest filing, from $2.0 billion in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $2.1 billion in Q1 2022 and bottomed at $2.0 billion in Q1 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $2.0 billion (2026), against an average of $2.1 billion.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) retreated 4.44%; it then increased 0.4% in 2025.
• Tracing BMY's Shares Outstanding (Weighted Average) over 5 years: stood at $2.1 billion in 2022, then dropped by 2.86% to $2.1 billion in 2023, then dropped by 2.03% to $2.0 billion in 2024, then increased by 0.35% to $2.0 billion in 2025, then advanced by 0.2% to $2.0 billion in 2026.
• Per Business Quant, the three latest BMY Shares Outstanding (Weighted Average) figures stand at $2.0 billion (Q1 2026), $2.0 billion (Q4 2025), and $2.0 billion (Q3 2025).

Peer Comparison